Alexander M. Gilderman

703 total citations · 1 hit paper
6 papers, 495 citations indexed

About

Alexander M. Gilderman is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Alexander M. Gilderman has authored 6 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Clinical Psychology, 2 papers in Psychiatry and Mental health and 1 paper in Pharmacology. Recurrent topics in Alexander M. Gilderman's work include Family Caregiving in Mental Illness (2 papers), Schizophrenia research and treatment (2 papers) and Medication Adherence and Compliance (1 paper). Alexander M. Gilderman is often cited by papers focused on Family Caregiving in Mental Illness (2 papers), Schizophrenia research and treatment (2 papers) and Medication Adherence and Compliance (1 paper). Alexander M. Gilderman collaborates with scholars based in United States. Alexander M. Gilderman's co-authors include Christine W. McGill, Javad Razani, Jeffrey L. Boyd, Howard B. Moss, Ian R. H. Falloon, Larry Ereshefsky and Simon Andrews and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Psychopharmacology and PubMed.

In The Last Decade

Alexander M. Gilderman

5 papers receiving 399 citations

Hit Papers

Family Management in the Prevention of Exacerbations of S... 1982 2026 1996 2011 1982 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander M. Gilderman United States 3 393 359 115 83 45 6 495
Alexander Gralnick United States 9 270 0.7× 161 0.4× 115 1.0× 71 0.9× 72 1.6× 46 451
Dolores Kreisman United States 7 265 0.7× 212 0.6× 124 1.1× 56 0.7× 39 0.9× 8 378
J.M. Bertolote Switzerland 4 301 0.8× 201 0.6× 158 1.4× 68 0.8× 49 1.1× 8 420
Warren Larkin United Kingdom 8 410 1.0× 294 0.8× 85 0.7× 94 1.1× 42 0.9× 12 530
Alison Holman United States 6 148 0.4× 253 0.7× 56 0.5× 139 1.7× 56 1.2× 6 397
Jonathan Mitchell United Kingdom 6 222 0.6× 263 0.7× 97 0.8× 82 1.0× 44 1.0× 7 371
Donna Downing United States 10 290 0.7× 236 0.7× 134 1.2× 53 0.6× 63 1.4× 13 424
Pětr Nawka Germany 11 340 0.9× 160 0.4× 76 0.7× 87 1.0× 70 1.6× 19 428
E Kuipers United Kingdom 7 244 0.6× 282 0.8× 127 1.1× 103 1.2× 56 1.2× 16 427
D. Goldberg United Kingdom 6 171 0.4× 165 0.5× 212 1.8× 68 0.8× 86 1.9× 9 368

Countries citing papers authored by Alexander M. Gilderman

Since Specialization
Citations

This map shows the geographic impact of Alexander M. Gilderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander M. Gilderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander M. Gilderman more than expected).

Fields of papers citing papers by Alexander M. Gilderman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander M. Gilderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander M. Gilderman. The network helps show where Alexander M. Gilderman may publish in the future.

Co-authorship network of co-authors of Alexander M. Gilderman

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander M. Gilderman. A scholar is included among the top collaborators of Alexander M. Gilderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander M. Gilderman. Alexander M. Gilderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gilderman, Alexander M., et al.. (1996). Promotion of OTC products within a network-model HMO.. PubMed. 9(6). 104–8. 1 indexed citations
2.
Gilderman, Alexander M., et al.. (1982). Substance-Induced Organic Mental Disorders. American Pharmacy. 22(9). 43–47. 1 indexed citations
3.
Falloon, Ian R. H., Jeffrey L. Boyd, Christine W. McGill, et al.. (1982). Family management in the prevention of exacerbations of schizophrenia. Journal of Clinical Psychopharmacology. 2(6). 427–427. 4 indexed citations
4.
Falloon, Ian R. H., Jeffrey L. Boyd, Christine W. McGill, et al.. (1982). Family Management in the Prevention of Exacerbations of Schizophrenia. New England Journal of Medicine. 306(24). 1437–1440. 484 indexed citations breakdown →
5.
Ereshefsky, Larry, et al.. (1979). Part II. Monitoring. Drug Intelligence & Clinical Pharmacy. 13(9). 492–497. 4 indexed citations
6.
Ereshefsky, Larry, et al.. (1979). Part I: Target Symptoms Pharmacology & Kinetics. Drug Intelligence & Clinical Pharmacy. 13(7-8). 403–408. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026